Alexander D'Amico
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alexander D'Amico
Alexander D'Amico is recorded as CFO at Cytosorbents Corp (CTSO). Cytosorbents Corp reported in an 8-K filed September 1, 2023 that Alexander D'Amico was terminated as Chief Financial Officer, effective August 28, 2023. Cytosorbents Corp reported in an 8-K filed July 19, 2023 that Alexander D'Amico was appointed Chief Financial Officer, effective August 7, 2023.
“On August 28, 2023, the Company and Mr. D'Amico mutually agreed to terminate Mr. D'Amico's employment with the Company.”
“On July 19, 2023, CytoSorbents Corporation (the “Company”) announced that it has entered into that certain Employment Agreement, dated as of July 10, 2023, by and between the Company and Alexander D’Amico (the “Employment Agreement”) pursuant to which Mr. D’Amico will serve as the Company’s Chief Financial Officer, effective as of August 7, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-07–present
-
2023-08-07–2023-08-28
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cytosorbents Corp
Other people whose current roles at this company are on record from its filings.
- Phillip Chan CEO, Board Member
- Kathleen Bloch CFO
- Peter J. Mariani CFO
- Peter Mariani CFO
- Vincent Capponi COO
- Vincent J. Capponi, MS COO
- Alan D. Sobel Board Member
- Edward R. Jones Board Member
- Jiny Kim Board Member
- Michael G. Bator Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.